Do EMA teleconferences leave your team exposed to vague minutes or unintended commitments? In this lesson, you’ll learn a regulator-calibrated communication model and reusable English phrases that deliver precise, auditable updates for drug–device and AI SaMD discussions. You’ll find clear explanations, phrase banks for core scenarios, structural scaffolds, and a 60‑second script—plus realistic examples and targeted exercises to lock in disciplined fact–interpretation–commitment language. Finish ready to speak in predictable patterns that reduce queries, align decisions, and accelerate submissions.
Precision English for EMA Submissions: Crafting Benefit–Risk Narratives for AI-Enabled Drug–Device Interfaces (how to phrase benefit–risk in EMA context for SaMD)Struggling to phrase AI-driven benefit–risk in EMA terms without overreach? In this lesson, you’ll learn to craft regulator-ready narratives for AI-enabled SaMD in drug–device combinations—anchoring EMA definitions, mapping evidence to claims, and applying a four-part template across RMP, PSUR, and device interfaces. Expect crisp explanations, annotated phrasing exemplars, and targeted exercises to lock in calibrated language and uncertainty handling. Leave with a reusable structure, harmonized terminology, and wording that shortens reviews and stands up to audit.